David L. Grange, Director at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 6,000 shares at $34.38 ($205K) on 2007-02-09, disclosed to the SEC on 2007-02-12.
Open-market sale of $205k PPDI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.97 | 779 | $26K | 12.9% |
| 2 | $34.00 | 1,558 | $53K | 25.9% |
| 3 | $34.11 | 1,169 | $40K | 19.5% |
| 4 | $34.16 | 779 | $27K | 13.0% |
| 5 | $34.25 | 390 | $13K | 6.5% |
| 6 | $34.38 | 1,325 |
| $46K |
| 22.2% |
| Total | $34.14 avg | 6,000 | $205K | 100% |
| Filing → |
| PPDI | SELL | 2008-08-08 | $418K | — | Filing → |
| PPDI | SELL | 2007-07-27 | $184K | — | Filing → |
| PPDI | SELL | 2006-05-24 | $362K | — | Filing → |